Neurvati Neurosciences
New York, New York, United States · Biotechnology, Health Care, Therapeutics
Neurvati Neurosciences is the neuroscience development platform of Blackstone Life Sciences, created to bridge the gap that has long constrained progress in the field. Neurvati identifies and advances high-potential neuroscience assets through a disciplined, scalable model that establishes and funds fit-for-purpose affiliate companies—each designed to drive development with precision, dedicated ca
Key facts
- Headquarters
- New York, New York, United States
- Employees
- Unknown
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- neurvati.com
- Company page
Recent activity at Neurvati Neurosciences
Leadership
- Elliott Ruiz, Chief Financial Officer
- J. Michael Ryan, M.D., Chief Medical Officer
- Carlos Martin, Chief Commercial Officer
Verified email and direct lines for Neurvati Neurosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Neurvati Neurosciences in the news
- Neurvati Neurosciences Strengthens Executive Leadership Team to Advance Next Phase of Growth at GRIN Therapeutics - PR Newswire (Aug 05, 2026)
- Radiprodil Significantly Reduces Seizure Frequency in Phase 1b Honeycomb Study of GRIN-Related Neurodevelopmental Disorder | NeurologyLive - Clinical Neurology News and Neurology Expert Insights - NeurologyLive (Sep 11, 2024)
- GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders - pharmaphorum (Jun 30, 2025)
- GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America - PR Newswire (May 27, 2025)
- GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe - PR Newswire (May 04, 2026)
- GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder - PR Newswire (Jan 09, 2026)
Companies similar to Neurvati Neurosciences
- Abcuro · Biotechnology, Health Care, Therapeutics
- ZoeNCure Therapeutics Pvt. Ltd · Biotechnology, Health Care, Therapeutics
- Amplifica Holdings Group · Biotechnology, Health Care, Therapeutics
- Oruka Therapeutics · Biotechnology, Health Care, Therapeutics
- NYU Langone Health · Biotechnology, Health Care, Therapeutics
About Neurvati Neurosciences: questions and answers
What does Neurvati Neurosciences do?
Neurvati Neurosciences is the neuroscience development platform of Blackstone Life Sciences, created to bridge the gap that has long constrained progress in the field. Neurvati identifies and advances high-potential neuroscience assets through a disciplined, scalable model that establishes and funds fit-for-purpose affiliate companies—each designed to drive development with precision, dedicated ca
Where is Neurvati Neurosciences headquartered?
Neurvati Neurosciences is headquartered in New York, New York, United States.
What is the latest news on Neurvati Neurosciences?
On Aug 05, 2026, Neurvati Appoints J. Michael Ryan as Chief Medical Officer and Elliott Ruiz as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy